Synthesis and biological evaluation of azido- and aziridino-hydroxyl- β-lactams through stereo- and regioselective epoxide ring opening

Journal of Organic Chemistry

Volumn 71, Issue 24, 2006, Pages 9229-9232

  Benfatti, Fides ^a   Cardillo, Giuliana ^a   Gentilucci, Luca ^a   Perciaccante, Rossana ^a   Tolomelli, Alessandra ^a   Catapano, Alberico ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; MOLECULAR STRUCTURE; STEREOCHEMISTRY; SYNTHESIS (CHEMICAL);

BIOACTIVE COMPOUNDS; BIOLOGICAL EVALUATION; EPOXIDE RING;

NITROGEN COMPOUNDS;

3 CHLOROPERBENZOIC ACID; AZIDE; AZIRIDINE DERIVATIVE; BETA LACTAM DERIVATIVE; CHOLESTEROL ACYLTRANSFERASE; EPOXIDE; EZETIMIBE; MEVINOLIN; ZIDOVUDINE;

ARTICLE; CHEMICAL BOND; CYCLOADDITION; DRUG SYNTHESIS; ENZYME INHIBITION; RING OPENING; STEREOCHEMISTRY;

AZIDES; AZIRIDINES; BETA-LACTAMS; EPOXY COMPOUNDS; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 33751584593     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0615652     Document Type: Article

References (45)

1. (a) Walsh, C. T. Nat. Rev. Microbiol. 2003, 1, 65-70.
2. (b) Raja, A.; Lebbos, J.; Kirkpatrick, P. Nat. Rev. Drug Discovery 2004, 3, 733-734.
3. (c) Singh, G. S. Mini Rev. Med. Chem. 2004, 4, 69-109.
4. (d) Fisher, J. F.; Meroueh, S. O.; Mobashery, S. Chem. Rev. 2005, 105, 395-424.
5. (e) Meegan, J. M.; Waldronm C. M.; Keaveny, R. D.; Neary, A. D. J. Chem. Res. 1997, 158-159.
6. (a) Abell, A. D.; Oldham, D. Bioorg. Med. Chem. Lett. 1999, 9, 497-500.
7. (b) Haley, T. M.; Angier, S. J.; Borthwick, A. D.; Singh, R.; Micetich, R. G. Drugs 2000, 3, 512-517.
8. (c) Mascaretti, O. A.; Boschetti, C. E.; Danelon, G. O.; Mata, E. G.; Roveri, A. A. Curr. Med. Chem. 1995, 1, 441-470.
9. (d) Edwards, P. D.; Bernstein, P. R. Med. Res. Rev. 1994, 14, 127-194.
10. (e) Zhou, N. E.; Guo, D.; Thomas, A. G.; Reddy, A. V. N.; Kaleta, J.; Purisima, E.; Menard, R.; Miceticha, R. G.; Singh, R. Bioorg. Med. Chem. Lett. 2003, 13, 139-141.
11. (a) Clader, J. W. Curr. Top. Med. Chem. 2005, 5, 231-233.
12. (b) Clader, J. W. Curr. Top. Med. Chem. 2005, 5, 243-256.
13. (c) Clader, J. W. Science 2004, 303, 1201-1204.
14. (d) Kvaerno, L.; Werder, M.; Hauser, H.; Carreira, E. M. J. Med. Chem. 2005, 48, 6035-6053.
15. Catapano, A.; Brady, W. E.; King, T. R.; Palmisano, J. Curr. Med. Res. Opin. 2005, 21, 1123-1130.
16. Benfatti, F.; Cardillo, G.; Fabbroni, S.; Gentilucci, L.; Perciaccante, R.; Piccinelli, F.; Tolomelli, A. Synthesis 2005, 61-70.
17. Palomo, C.; Aizpurua, J. M.; Ganboa, I.; Oiarbide, M. Eur. J. Org. Chem. 1999, 12, 3223-3235.
18. (a) Cardillo, G.; Fabbroni, S.; Gentilucci, L.; Perciaccante, R.; Piccinelli, F.; Tolomelli, A. Org. Lett. 2005, 7, 533-536.
19. (b) Cardillo, G.; Fabbroni, S.; Gentilucci, L.; Perciaccante, R.; Tolomelli, A. Adv. Synth. Catal. 2005, 347, 833-838.
20. (a) Lee, D. L.; Rapoport, H. J. Org. Chem. 1975, 40, 3491-3496.
21. (b) Baldwin, J. E.; Otsuka, M.; Wallace, P. M. Tetrahedron 1986, 42, 3097-3110.
22. Griffin, R. J. Prog. Med. Chem. 1994, 31, 121-232.
23. Benfatti, F.; Cardillo, G.; Gentilucci, L.; Perciaccante, R.; Tolomelli, A. Synlett 2005, 2204-2206.
24. 2 = 0.769. ORTEP plot is reported in Supporting Information.
25. Structures calculated with AMI (HYPERCHEM 7.0 package).
26. See Supporting Information.
27. Benedetti, F.; Berti, F.; Norbedo, S. Tetrahedron Lett. 1998, 39, 7971-7974.
28. Davis, C. E. D.; Bailey, J. L.; Lockner, J. W.; Coates, R. M. J. Org. Chem. 2003, 68, 75-82.
29. (a) Nyffeler, P. T; Liang, C.-H.; Koeller, K. M; Wong, C.-H. J. Am. Chem. Soc. 2002, 124, 10773-78.
30. (b) Yamashita, M.; Ojima, I. J. Am. Chem. Soc. 1983, 105, 6339-6342.
31. (c) Boyer, J. H. J. Am. Chem. Soc. 1951, 73, 5865-5866.
32. (a) Staudinger, H.; Meyer, J. Helv. Chim. Acta 1919, 2, 635.
33. (b) Gololobov, Y. G.; Zhmurova, I. N.; Kasukhin, L. F. Tetrahedron 1981, 37, 437-472.
34. (c) Multzer, J.; Becker, R.; Brunner, E. J. Am. Chem. Soc. 1989, 111, 7500-7504.
35. (d) Legters, J.; Thijs, L.; Zwanenburg, B. Tetrahedron 1991, 47, 5287-94.
36. (e) Velasco, M. D.; Molina, P.; Fresneda, P. M.; Sanz, M. A. Tetrahedron 2000, 56, 4079-4084.
37. Ibuka, T. Chem. Soc. Rev. 1998, 27, 145-154.
38. (a) Saxon, E.; Armstrong, J. I.; Bertozzi, C. R. Org. Lett. 2000, 2, 2141-2143.
39. (b) Lin, F. L.; Hoyt, H. M.; van Halbeek, H.; Bergman, R. G.; Bertozzi, C. R. J. Am. Chem. Soc. 2005, 127, 2686-2695.
40. Ibuka, T. Chem. Soc. Rev. 1998, 27, 145-154.
41. 14C]palmitoyl CoA (18 μM) as a substrate in 1 % DMSO-0.2 M potassium phosphate buffer (pH 7.4) and 1.5 mg/mL bovine serum albumin at 25°C.
42. (a) Largis, E. E.; Wang, C. H.; DeVries, V. G.; Schaffer, S. A. J. Lipid Res. 1989, 30, 681-689.
43. (b) Sliskovic, D. R.; White, A. D. Trends Pharmacol. Sci. 1991, 12, 194-199.
44. Leon, C.; Hill, J. S.; Wasan, K. M. Pharm. Res. 2005, 10, 1578-1588.
45. Clader, J. W.; Burnett, D. A.; Caplen, M. A.; Domalski, M. S.; Dugar, S.; Vaccaro, W.; Sher, R.; Browne, M. E.; Zhao, H.; Burrier, R. E.; Salisbury, B.; Davis, H. R., Jr. J. Med. Chem. 1996, 39, 3684-3693.